lanraplenib (GS-9876) - Gilead, Galapagos, Ignota Labs
entospletinib (GS-9973) - Ignota Labs
istisociclib (KB-0742) - Ignota Labs
https://www.businesswire.com/news/home/20251005158956/en/Ignota-Labs-Acquires-Kronoss-Clinical-Pipeline
 
Oct 6, 2025
 
Next